Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.5 USD | +0.96% | -1.21% | +352.72% |
Jul. 03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
Jul. 03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 8K | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 13G | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- 0R34 Stock
- News Johnson & Johnson
- Official Publications